Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lynd, Larry D.
Funding for this research was provided by:
Canadian Institutes for Health Research
Canadian Agency for Drugs and Technologies in Health (C-150390)